The International Journal of Tuberculosis and Lung Disease

Why has zoonotic tuberculosis not received much attention? [Editorial]
pp. 1073-1074(2)
Authors: Thoen, Charles O.; LoBue, Philip A.; de Kantor, Isabel

Tuberculosis in humans and animals: an overview [Serialised article. Tuberculosis: a re-emerging disease in animals and humans. Number 1 in the series]
pp. 1075-1078(4)
Authors: LoBue, P.A.; Enarson, D.A.; Thoen, C.O.

Respiratory health effects of indoor air pollution [Review article]
pp. 1079-1086(8)
Authors: Perez-Padilla, R.; Schilmann, A.; Riojas-Rodriguez, H.

Laboratory tests focusing on sputum [Year in review 2009]
pp. 1087-1093(7)
Author: Urbanczik, R.

Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB? [Unresolved issues]
pp. 1094-1096(3)
Authors: Edginton, M.E.; Miller, D.L.; Burney, P.; El Sony, A.I.; Lwilla, F.I.; O'Brien, R.; Roldan, M.B.; Roldan, A.; Srinath, S.

Factors influencing performance of Global Fund-supported tuberculosis grants
pp. 1097-1103(7)
Authors: Katz, I.; Aziz, M.A.; Olszak-Olszewski, M.; Komatsu, R.; Low-Beer, D.; Atun, R.

Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience
pp. 1104-1111(8)
Authors: Hirsch-Moverman, Y.; Bethel, J.; Colson, P.W.; Franks, J.; El-Sadr, W.

Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases
pp. 1112-1119(8)
Authors: Morán-Mendoza, O.; Marion, S.A.; Elwood, K.; Patrick, D.; FitzGerald, J.M.

Tuberculosis transmission risk and infection control in a hospital emergency department in Lima, Peru
pp. 1120-1126(7)
Authors: Escombe, A.R.; Huaroto, L.; Ticona, E.; Burgos, M.; Sanchez, I.; Carrasco, L.; Farfán, E.; Flores, F.; Moore, D.A.J.

Application of modern microbiological diagnostic methods for tuberculosis in Macha, Zambia
pp. 1127-1131(5)
Authors: Verweij, K.E.; Kamerik, A.R.; van Ingen, J.; van Dijk, J.H.; Sikwangala, P.; Thuma, P.; Nouwen, J.L.; van Soolingen, D.

Why do tuberculosis patients default in Tashkent City, Uzbekistan? A qualitative study
pp. 1132-1139(8)
Authors: Hasker, E.; Khodjikhanov, M.; Sayfiddinova, S.; Rasulova, G.; Yuldashova, U.; Uzakova, G.; Butabekov, I.; Veen, J.; van der Werf, M.J.; Lefèvre, P.

Piloting the use of personal digital assistants for tuberculosis and human immunodeficiency virus surveillance, Kenya, 2007
pp. 1140-1146(7)
Authors: Auld, A.F.; Wambua, N.; Onyango, J.; Marston, B.; Namulanda, G.; Ackers, M.; Oluoch, T.; Karisa, A.; Hightower, A.; Shiraishi, R.W.; Nakashima, A.; Sitienei, J.

Serum 25-hydroxy-vitamin D₃ concentrations increase during tuberculosis treatment in Tanzania
pp. 1147-1152(6)
Authors: Tostmann, A.; Wielders, J.P.M.; Kibiki, G.S.; Verhoef, H.; Boeree, M.J.; van der Ven, A.J.A.M.

Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis
pp. 1153-1158(6)
Authors: Seiscento, M.; Vargas, F.S.; Acencio, M.M.P.; Teixeira, L.R.; Capelozzi, V.L.; Sales, R.K.B.; Antonangelo, L.

Association of P2X₇ receptor +1513 (A→C) polymorphism with tuberculosis in a Punjabi population
pp. 1159-1163(5)
Authors: Sharma, S.; Kumar, V.; Khosla, R.; Kajal, N.; Sarin, B.; Sehajpal, P.

Concentration of Mycobacterium tuberculosis from sputum using ligand-coated magnetic beads
pp. 1164-1168(5)
Authors: Wilson, S.; Lane, A.; Rosedale, R.; Stanley, C.

Evaluation of MGIT 960™ and the colorimetric-based method for tuberculosis drug susceptibility testing
pp. 1169-1175(7)
Authors: Morcillo, N.; Imperiale, B.; Di Giulio, B.

The changing pattern of clinical Mycobacterium avium isolation in the Netherlands
pp. 1176-1180(5)
Authors: van Ingen, J.; Hoefsloot, W.; Dekhuijzen, P.N.R.; Boeree, M.J.; van Soolingen, D.

The challenge of osteo-articular tuberculosis in the twenty-first century: a 15-year population-based study
pp. 1181-1186(6)
Authors: Lešić, A.R.; Pešut, D.P.; Marković-Denić, L.; Maksimović, J.; Čobeljić, G.; Milošević, I.; Atkinson, H.D.E.; Bumbaširević, M.

Frequency of adverse events and mortality in patients with pleural empyema in a public referral hospital in Mexico City
pp. 1187-1192(6)
Authors: Herrera-Kiengelher, L.; Báez-Saldaña, R.; Salas-Hernández, J.; Avalos-Bracho, A.; Pérez-Padilla, R.; Torre-Bouscoulet, L.

Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease
pp. 1193-1200(8)
Authors: Chan, K.H.; Yeung, S.C.; Yao, T.J.; Ip, M.S.M.; Cheung, A.H.K.; Chan-Yeung, M.M.W.; Mak, J.C.W.; COPD Study Group of the Hong Kong Thoracic Society,

Beijing family Mycobacterium tuberculosis isolated from throughout Japan: phylogeny and genetic features [Short communication]
pp. 1201-1204(4)
Authors: Maeda, S.; Wada, T.; Iwamoto, T.; Murase, Y.; Mitarai, S.; Sugawara, I.; Kato, S.

Feasibility of the T-SPOT®.TB assay for the immunodiagnosis of smear-positive pulmonary tuberculosis using induced sputum [Short communication]
pp. 1205-1208(4)
Authors: Dilektasli, A.G.; Erdem, E.; Durukan, E.; Eyüboğlu, F..

Predictive values of QuantiFERON®-TB Gold testing in screening for tuberculosis disease in asylum seekers [Short communication]
pp. 1209-1211(3)
Authors: Harstad, I.; Winje, B.A.; Heldal, E.; Oftung, F.; Jacobsen, G.W.

Can the drug-driven dependency and deprivation effect be used as a therapeutic tool in tuberculous patients? [Correspondence]
pp. 1212-1212(1)
Authors: André, Nicolas; Pasquier, Eddy

In reply to `Can the drug-driven dependency and deprivation effect be used as a therapeutic tool in tuberculous patients?' [Correspondence]
pp. 1213-1213(1)
Authors: Zhong, Min; Zhu, Bingdong; Zhang, Wenhong; Zhang, Ying

Anti-tuberculosis drug resistance in Dohuk, Iraq [Correspondence]
pp. 1213-1214(2)
Authors: Merza, Muayad A.; Farnia, Parissa; Masjedi, Mohammad Reza; Ridell, Malin